The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Splitting a vial for two laboratories: how to do it without ruining both

This is a generated summary. It shows the 9 most-liked posts from a topic of 71, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
GE
g.ekstromTL25 Mar 2025#1

Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable.

Something about splitting a vial does not reconcile and I would like a second pair of eyes before I decide which half is wrong.

Two sources, both reputable, giving figures that cannot both be right unless they are measuring different quantities. My suspicion is that they are, and I cannot see how.

24 likes 17mo
VR
v.rautioTL2 Solution26 Mar 2025#9
ar.kravchenko, post #3: The opening post put the caveat in the right place and I want to underline it. The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time. Go to post

Coming back to post #7, because the follow-up matters more than the original answer.

Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want.

Two people can read the same figure differently here and both be reasonable.

12 likes in reply to #3 16mo
NV
n.vukovicTL230 Mar 2025#11

This follows post #8 rather than contradicting it.

I would be cautious about generalising from the splitting a vial example above. It is a good example. It is one example.

26 likes 16mo
SL
s.leclercTL4 Moderator23 Apr 2025#25
appeals_desk, post #14: Practical experience of splitting a vial, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable. Go to post

On post #23 — agreed on the reasoning, with one qualification.

Cross-checking one lot with two services independently is the cleanest test available and is rarely done because it costs twice as much.

That is the version I use. It may not be the version that is correct.

28 likes in reply to #14 15mo
SE
septum_entryTL2Member13 May 2025#38
a.teixeira, post #15: Picking up post #12: that is the part I would want checked first. Splitting a vial was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread. Go to post

Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and selective reporting. The extra effort is worth it.

If this contradicts something upthread, the upthread version may well be the better one.

25 likes in reply to #15 15mo
BS
buffer_sheetTL3Regular19 May 2025 · edited#42
a.coelho, post #35: Answering the splitting a vial question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the first measurement was taken. Go to post

Post #41 is the version of this I will quote in future. One addition.

Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not establish a pattern.

26 likes in reply to #35 14mo
MD
m.dumitruTL24 Jun 2025 · edited#54

Everything in post #50 holds. The case it does not cover is the one I have.

Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.

Someone should write this up properly, and it should probably not be me.

28 likes 14mo
JR
j.restrepoTL217 Jun 2025#64
cannula_trace, post #10: The four services answer different questions. A documentation review cannot tell you what is in a vial and a purity assay cannot tell you whether the records are internally consistent. One of those cases where knowing the mechanism does not help the decision. Go to post

That is a cleaner way of putting what I was circling around.

31 likes in reply to #10 13mo
CR
compounding_ruthTL4Pharmacist26 Jun 2025#71

I changed my mind about splitting a vial after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens.

23 likes 13mo

Read the full topic (71 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Second pass at: Submitting a sample: the process end to end
Second pass at: Submitting a sample: the process end to end Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Submitting a sample. It is mine, it is…
MARAMAVDNA+12 16 41k 4mo
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin Aggregate verification…
PMPMDBAACB+22 26 23k 17mo
Turnaround times and what they mean for a decision — one year on
On the subject in the title: Turnaround times and what they mean for a decision — one year on Working notes rather than a conclusion. Reading back through what has been written here about Turnaround times,…
TVZVGFFEDI+25 29 22k 18mo
Chain of custody for a sample you posted yourself — one year on
Posting this under the heading it deserves: Chain of custody for a sample you posted yourself — one year on Everything below is what sits behind that. Posting a small dataset on Chain of custody. It is mine,…
TVHFRVRDKF+28 32 50k 15h
Chain of custody for a sample you posted yourself
Chain of custody for a sample you posted yourself Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about chain of custody in a thread last spring and I would like…
MRSGPN 2 7.3k 5h

Related topics — sharing the tags blind sampling, PeptideMeter, third-party testing

TopicParticipantsRepliesViewsActivity
Choosing which test to pay for, given a fixed budget
On the subject in the title: Choosing which test to pay for, given a fixed budget Working notes rather than a conclusion. A question about how a record should be read rather than about a supplier. We have…
REANKRJPK+60 70 49k 3mo
Second pass at: What "verified" means on our vendor pages, stated narrowly
Second pass at: What "verified" means on our vendor pages, stated narrowly — setting out what I have, and where I think it stops being reliable. A question about how a record should be read rather than about…
JHNVMVSSM+94 102 20k 3mo
A report I filed that turned out to be wrong, and the correction
A report I filed that turned out to be wrong, and the correction Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
DOCIAKSGVR+124 132 12k 13mo
Documenting a supplier's response to a discrepancy — does this still hold?
Documenting a supplier's response to a discrepancy — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Structured question about turnaround and…
FRTHSAFNLV+47 52 58k 16mo
About the Independent verification category
Janoshik, Medutest, PeptideMeter and VendorInvestigate results, how to submit a sample, and how to read what comes back. This post is a community wiki: any member at trust level 3 or above can edit it, and…
KSLFDCCM+1 5 5.8k 23h